Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2012

01-06-2012 | Original Article

Clinical Characteristics of Young-Onset Ischemic Colitis

Authors: Takefumi Kimura, Akihiro Shinji, Akira Horiuchi, Naoki Tanaka, Tadanobu Nagaya, Takashi Shigeno, Naoshi Nakamura, Michiharu Komatsu, Takeji Umemura, Norikazu Arakura, Akihiro Matsumoto, Eiji Tanaka

Published in: Digestive Diseases and Sciences | Issue 6/2012

Login to get access

Abstract

Background

Ischemic colitis (IC) typically develops in the elderly, where hypertension, cerebrocardiovascular disease, and past history of abdominal surgery are regarded as risk factors. Although there have been reports of younger patients with IC, its clinical features remain unclear.

Aim

The aim of this study was to clarify the clinical characteristics of IC in young adults.

Methods

Three hundred fifty-nine patients were diagnosed as having IC at five hospitals across Nagano prefecture, Japan. Clinical data were compared between the young patient group [20–45 years, n = 53 (15%)] and the elderly patient group [>45 years, n = 306 (85%)], as well as with age- and gender-matched healthy individuals (n = 156).

Results

The presence of a smoking habit and hyperuricemia were significantly higher in the young patient group compared with the elderly patient group (42 vs. 19%, P = 0.001 and 8 vs. 1%, P = 0.019, respectively), which was confirmed by multiple logistic regression analysis (P = 0.001, odds ratio 3.239 and P = 0.028, odds ratio 16.907, respectively). Additionally, multiple logistic regression analysis of the young IC patient group and age- and gender-matched healthy individuals demonstrated that these two factors were strongly associated with IC development (P = 0.008, odds ratio 2.49 for smoking habit and P = 0.039, odds ratio 6.37 for hyperuricemia).

Conclusions

High prevalences of a smoking habit and hyperuricemia are characteristic features of IC in the young adult population.
Literature
1.
go back to reference Boley SJ, Schwartz S, Lash J, Sternhill V. Reversible vascular occlusion of colon. Surg Gynecol Obstet. 1963;116:53–60.PubMed Boley SJ, Schwartz S, Lash J, Sternhill V. Reversible vascular occlusion of colon. Surg Gynecol Obstet. 1963;116:53–60.PubMed
3.
go back to reference Medina C, Vilaseca J, Videla S, Fabra R, Armengol-Miro JR, Malagelada JR. Outcome of patients with ischemic colitis: review of fifty-three cases. Dis Colon Rectum. 2004;47:180–184.PubMedCrossRef Medina C, Vilaseca J, Videla S, Fabra R, Armengol-Miro JR, Malagelada JR. Outcome of patients with ischemic colitis: review of fifty-three cases. Dis Colon Rectum. 2004;47:180–184.PubMedCrossRef
4.
go back to reference Cubiella Fernández J, Núñez Calvo L, González Vázquez E, et al. Risk factors associated with the development of ischemic colitis. World J Gastroenterol. 2010;16:4564–4569.PubMedCrossRef Cubiella Fernández J, Núñez Calvo L, González Vázquez E, et al. Risk factors associated with the development of ischemic colitis. World J Gastroenterol. 2010;16:4564–4569.PubMedCrossRef
5.
go back to reference Longo WE, Ballantyne GH, Gusberg RJ. Ischemic colitis—patterns and prognosis. Dis Colon Rectum. 1992;35:726–730.PubMedCrossRef Longo WE, Ballantyne GH, Gusberg RJ. Ischemic colitis—patterns and prognosis. Dis Colon Rectum. 1992;35:726–730.PubMedCrossRef
6.
go back to reference Arnott ID, Ghosh S, Ferguson A. The spectrum of ischaemic colitis. Eur J Gastroenterol Hepatol. 1999;11:295–303.PubMedCrossRef Arnott ID, Ghosh S, Ferguson A. The spectrum of ischaemic colitis. Eur J Gastroenterol Hepatol. 1999;11:295–303.PubMedCrossRef
7.
8.
go back to reference Walker AM, Bohn RL, Cali C, Cook SF, Ajene AN, Sands BE. Risk factors for colon ischemia. Am J Gastroenterol. 2004;99:1333–1337.PubMedCrossRef Walker AM, Bohn RL, Cali C, Cook SF, Ajene AN, Sands BE. Risk factors for colon ischemia. Am J Gastroenterol. 2004;99:1333–1337.PubMedCrossRef
9.
go back to reference Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M. Fatal colonic ischemia: a population-based study. Scand J Gastroenterol. 2006;41:1312–1319.PubMedCrossRef Acosta S, Ogren M, Sternby NH, Bergqvist D, Björck M. Fatal colonic ischemia: a population-based study. Scand J Gastroenterol. 2006;41:1312–1319.PubMedCrossRef
10.
go back to reference Scharff JR, Longo WE, Vartanian SM, Jacobs DL, Bahadursingh AN, Kaminski DL. Ischemic colitis: spectrum of disease and outcome. Surgery. 2003;134:624–629.PubMedCrossRef Scharff JR, Longo WE, Vartanian SM, Jacobs DL, Bahadursingh AN, Kaminski DL. Ischemic colitis: spectrum of disease and outcome. Surgery. 2003;134:624–629.PubMedCrossRef
11.
12.
go back to reference Habu Y, Tahashi Y, Kiyota K, et al. Reevaluation of clinical features of ischemic colitis—analysis of 68 consecutive cases diagnosed by early colonoscopy. Scand J Gastroenterol. 1996;31:881–886.PubMedCrossRef Habu Y, Tahashi Y, Kiyota K, et al. Reevaluation of clinical features of ischemic colitis—analysis of 68 consecutive cases diagnosed by early colonoscopy. Scand J Gastroenterol. 1996;31:881–886.PubMedCrossRef
13.
go back to reference Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Aliment Pharmacol Ther. 2007;25:681–692.PubMedCrossRef Suh DC, Kahler KH, Choi IS, Shin H, Kralstein J, Shetzline M. Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Aliment Pharmacol Ther. 2007;25:681–692.PubMedCrossRef
14.
go back to reference Preventza OA, Lazarides K, Sawyer MD. Ischemic colitis in young adults: a single-institution experience. J Gastrointest Surg. 2001;5:388–392.PubMedCrossRef Preventza OA, Lazarides K, Sawyer MD. Ischemic colitis in young adults: a single-institution experience. J Gastrointest Surg. 2001;5:388–392.PubMedCrossRef
15.
go back to reference Barcewicz PA, Welch JP. Ischemic colitis in young-adult patients. Dis Colon Rectum. 1980;23:109–114.PubMedCrossRef Barcewicz PA, Welch JP. Ischemic colitis in young-adult patients. Dis Colon Rectum. 1980;23:109–114.PubMedCrossRef
16.
go back to reference Deana DG, Dean PJ. Reversible ischemic colitis in young-women—association with oral-contraceptive use. Am J Surg Pathol. 1995;19:454–462.PubMedCrossRef Deana DG, Dean PJ. Reversible ischemic colitis in young-women—association with oral-contraceptive use. Am J Surg Pathol. 1995;19:454–462.PubMedCrossRef
17.
go back to reference Linder JD, Monkemuller KE, Raijman I, Johnson L, Lazenby AJ, Wilcox CM. Cocaine-associated ischemic colitis. South Med J. 2000;93:909–913.PubMed Linder JD, Monkemuller KE, Raijman I, Johnson L, Lazenby AJ, Wilcox CM. Cocaine-associated ischemic colitis. South Med J. 2000;93:909–913.PubMed
18.
go back to reference Holubar SD, Hassinger JP, Dozois EJ, Masuoka HC. Methamphetamine colitis a rare case of ischemic colitis in a young patient. Arch Surg. 2009;144:780–782.PubMedCrossRef Holubar SD, Hassinger JP, Dozois EJ, Masuoka HC. Methamphetamine colitis a rare case of ischemic colitis in a young patient. Arch Surg. 2009;144:780–782.PubMedCrossRef
19.
go back to reference Green BT, Branch MS. Ischemic colitis in a young adult during sickle cell crisis: case report and review. Gastrointest Endosc. 2003;57:605–607.PubMedCrossRef Green BT, Branch MS. Ischemic colitis in a young adult during sickle cell crisis: case report and review. Gastrointest Endosc. 2003;57:605–607.PubMedCrossRef
20.
go back to reference Moses FM. Gastrointestinal-bleeding and the athlete. Am J Gastroenterol. 1993;88:1157–1159.PubMed Moses FM. Gastrointestinal-bleeding and the athlete. Am J Gastroenterol. 1993;88:1157–1159.PubMed
21.
go back to reference Theodoropoulou A, Sfiridaki A, Oustamanolakis P, et al. Genetic risk factors in young patients with ischemic colitis. Clin Gastroenterol Hepatol. 2008;6:907–911.PubMedCrossRef Theodoropoulou A, Sfiridaki A, Oustamanolakis P, et al. Genetic risk factors in young patients with ischemic colitis. Clin Gastroenterol Hepatol. 2008;6:907–911.PubMedCrossRef
22.
go back to reference Tohda G, Higashi S, Sumiyoshi K, Sakumoto H, Kato C, Kane T. Evaluation of clinical features of ischemic colitis: comparison between young and elderly. Dig Endosc. 2005;17:123–130.CrossRef Tohda G, Higashi S, Sumiyoshi K, Sakumoto H, Kato C, Kane T. Evaluation of clinical features of ischemic colitis: comparison between young and elderly. Dig Endosc. 2005;17:123–130.CrossRef
23.
go back to reference Matsumoto T, Iida M, Kimura Y, Nanbu T, Fujishima M. Clinical features in young adult patients with ischaemic colitis. J Gastroenterol Hepatol. 1994;9:572–575.PubMedCrossRef Matsumoto T, Iida M, Kimura Y, Nanbu T, Fujishima M. Clinical features in young adult patients with ischaemic colitis. J Gastroenterol Hepatol. 1994;9:572–575.PubMedCrossRef
24.
go back to reference Scowcroft CW, Sanowski RA, Kozarek RA. Colonoscopy in ischemic colitis. Gastrointest Endosc. 1981;27:156–161.PubMedCrossRef Scowcroft CW, Sanowski RA, Kozarek RA. Colonoscopy in ischemic colitis. Gastrointest Endosc. 1981;27:156–161.PubMedCrossRef
25.
go back to reference Dawson MA, Schaefer JW. The clinical course of reversible ischemic colitis. Observations on the progression of sigmoidoscopic and histological changes. Gastroenterology. 1971;60:577–580.PubMed Dawson MA, Schaefer JW. The clinical course of reversible ischemic colitis. Observations on the progression of sigmoidoscopic and histological changes. Gastroenterology. 1971;60:577–580.PubMed
26.
go back to reference Forde KA, Lebwohl O, Wolff M, Voorhees AB. The endoscopy corner: reversible ischemic colitis—correlation of colonoscopic and pathologic changes. Am J Gastroenterol. 1979;72:182–185.PubMed Forde KA, Lebwohl O, Wolff M, Voorhees AB. The endoscopy corner: reversible ischemic colitis—correlation of colonoscopic and pathologic changes. Am J Gastroenterol. 1979;72:182–185.PubMed
27.
go back to reference Nagaya T, Tanaka N, Suzuki T, et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 2010;53:724–731.PubMedCrossRef Nagaya T, Tanaka N, Suzuki T, et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 2010;53:724–731.PubMedCrossRef
28.
go back to reference Tanaka N, Horiuchi A, Yokoyama T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758–768.PubMedCrossRef Tanaka N, Horiuchi A, Yokoyama T, et al. Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy. J Gastroenterol. 2011;46:758–768.PubMedCrossRef
29.
go back to reference Hatta T, Fujinaga Y, Kadoya M, et al. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol. 2010;45:1263–1271.PubMedCrossRef Hatta T, Fujinaga Y, Kadoya M, et al. Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease. J Gastroenterol. 2010;45:1263–1271.PubMedCrossRef
30.
go back to reference Komatsu M, Yazaki M, Tanaka N, et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol. 2008;49:810–820.PubMedCrossRef Komatsu M, Yazaki M, Tanaka N, et al. Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. J Hepatol. 2008;49:810–820.PubMedCrossRef
31.
go back to reference Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–418.PubMedCrossRef Tanaka N, Sano K, Horiuchi A, Tanaka E, Kiyosawa K, Aoyama T. Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis. J Clin Gastroenterol. 2008;42:413–418.PubMedCrossRef
32.
go back to reference Tsuruta G, Tanaka N, Hongo M, et al. Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol. 2010;45:666–672.PubMedCrossRef Tsuruta G, Tanaka N, Hongo M, et al. Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits. J Gastroenterol. 2010;45:666–672.PubMedCrossRef
33.
go back to reference Tsutsui M, Tanaka N, Kawakubo M, et al. Serum fragmented cytokeratin 18 levels reflect the histological activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. J Clin Gastroenterol. 2010;44:440–447.PubMed Tsutsui M, Tanaka N, Kawakubo M, et al. Serum fragmented cytokeratin 18 levels reflect the histological activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels. J Clin Gastroenterol. 2010;44:440–447.PubMed
34.
go back to reference Locke GR, Pemberton JH, Phillips SF. American gastroenterological association medical position statement: guidelines on constipation. Gastroenterology. 2000;119:1761–1766.PubMedCrossRef Locke GR, Pemberton JH, Phillips SF. American gastroenterological association medical position statement: guidelines on constipation. Gastroenterology. 2000;119:1761–1766.PubMedCrossRef
35.
go back to reference Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2004;24:1031–1036.PubMedCrossRef Jaimes EA, DeMaster EG, Tian RX, Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol. 2004;24:1031–1036.PubMedCrossRef
36.
go back to reference Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens. 2001;19:891–897.PubMedCrossRef Raij L, DeMaster EG, Jaimes EA. Cigarette smoke-induced endothelium dysfunction: role of superoxide anion. J Hypertens. 2001;19:891–897.PubMedCrossRef
37.
go back to reference Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA. 1995;273:1047–1053.PubMedCrossRef Glantz SA, Parmley WW. Passive smoking and heart disease. Mechanisms and risk. JAMA. 1995;273:1047–1053.PubMedCrossRef
38.
go back to reference Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684–2698.PubMedCrossRef Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111:2684–2698.PubMedCrossRef
39.
go back to reference Sánchez-Lozada LG, Soto V, Tapia E, et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008;295:F1134–F1141.PubMedCrossRef Sánchez-Lozada LG, Soto V, Tapia E, et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol. 2008;295:F1134–F1141.PubMedCrossRef
40.
go back to reference Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25:39–42.PubMedCrossRef Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25:39–42.PubMedCrossRef
41.
go back to reference Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183–1190.PubMedCrossRef Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183–1190.PubMedCrossRef
42.
go back to reference Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404–2410.PubMedCrossRef Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National Health and Nutrition Examination Survey. JAMA. 2000;283:2404–2410.PubMedCrossRef
43.
go back to reference Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med. 1999;131:7–13.PubMed Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham heart study. Ann Intern Med. 1999;131:7–13.PubMed
44.
go back to reference Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87:76–79.PubMed Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993;87:76–79.PubMed
45.
go back to reference Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266:H874–H880.PubMed Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extract contracts isolated porcine coronary arteries by superoxide anion-mediated degradation of EDRF. Am J Physiol. 1994;266:H874–H880.PubMed
46.
go back to reference Sugiyama S, Kugiyama K, Ohgushi M, et al. Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract. Cardiovasc Res. 1998;38:508–515.PubMedCrossRef Sugiyama S, Kugiyama K, Ohgushi M, et al. Supersensitivity of atherosclerotic artery to constrictor effect of cigarette smoke extract. Cardiovasc Res. 1998;38:508–515.PubMedCrossRef
47.
go back to reference Sánchez-Lozada LG, Tapia E, Santamaría J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67:237–247.PubMedCrossRef Sánchez-Lozada LG, Tapia E, Santamaría J, et al. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. Kidney Int. 2005;67:237–247.PubMedCrossRef
48.
go back to reference Zharikov SI, Swenson ER, Lanaspa M, Block ER, Patel JM, Johnson RJ. Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses. 2010;74:1069–1074.PubMedCrossRef Zharikov SI, Swenson ER, Lanaspa M, Block ER, Patel JM, Johnson RJ. Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? Med Hypotheses. 2010;74:1069–1074.PubMedCrossRef
49.
go back to reference Villegas R, Xiang YB, Cai Q, et al. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2010;8:263–270.PubMedCrossRef Villegas R, Xiang YB, Cai Q, et al. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2010;8:263–270.PubMedCrossRef
50.
go back to reference Nishida Y, Iyadomi M, Higaki Y, Tanaka H, Hara M, Tanaka K. Influence of physical activity intensity and aerobic fitness on the anthropometric index and serum uric acid concentration in people with obesity. Intern Med. 2011;50:2121–2128.PubMedCrossRef Nishida Y, Iyadomi M, Higaki Y, Tanaka H, Hara M, Tanaka K. Influence of physical activity intensity and aerobic fitness on the anthropometric index and serum uric acid concentration in people with obesity. Intern Med. 2011;50:2121–2128.PubMedCrossRef
Metadata
Title
Clinical Characteristics of Young-Onset Ischemic Colitis
Authors
Takefumi Kimura
Akihiro Shinji
Akira Horiuchi
Naoki Tanaka
Tadanobu Nagaya
Takashi Shigeno
Naoshi Nakamura
Michiharu Komatsu
Takeji Umemura
Norikazu Arakura
Akihiro Matsumoto
Eiji Tanaka
Publication date
01-06-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2088-5

Other articles of this Issue 6/2012

Digestive Diseases and Sciences 6/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.